Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2025-08-26 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
2025年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2025 年半年度财务报告" which translates to "2025 Half-Year Financial Report." It contains detailed financial statements including consolidated and parent company balance sheets, profit and loss statements, cash flow statements, and changes in equity for the half-year period ending June 30, 2025. The presence of comprehensive financial data and analysis for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document length is substantial (15,000 characters), and it contains actual financial statements rather than just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
关于拟变更会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed change of the company's auditor (accounting firm) for the upcoming fiscal year 2025. It details the new auditor's qualifications, the reasons for the change, the communication with the previous auditor, and the approvals by the audit committee and board of directors. It does not contain any financial statements or audit reports themselves, but rather the procedural and governance information about the auditor change. This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about auditor change and not the audit report itself or an annual/interim report.
2025-08-26 Chinese
2025年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2025 半年度报告摘要" which translates to "2025 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. It also discusses important events related to shareholder changes and judicial auction of shares. The document is comprehensive and includes substantive financial data and analysis for a period shorter than a full fiscal year, which fits the definition of an Interim / Quarterly Report (IR). The document length is 3784 characters, which is typical for a summary but still contains actual financial data, not just an announcement or a link to a report. Therefore, it should be classified as an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 95% confidence The document is a summary table detailing non-operating fund occupation and other related party fund transactions for the period January to June 2025. It contains specific financial data such as balances, amounts occupied, interest, and repayments related to affiliated companies and subsidiaries. The document is relatively short (1746 characters) and is a detailed financial summary for a half-year period, including substantive financial data and analysis. This fits the definition of an Interim / Quarterly Report (IR), which covers comprehensive financial data for a period shorter than a full fiscal year. It is not an announcement or a certification, but actual financial data presentation. H1 2025
2025-08-26 Chinese
2025年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 年半年度报告全文" which translates to the "2025 Semi-Annual Report Full Text". It contains detailed financial data, management discussion and analysis, company overview, financial indicators, and other substantive financial and operational information for the period January 1, 2025 to June 30, 2025. The length is substantial (15,000 characters), and it includes actual financial statements and analysis rather than just an announcement or certification. The content matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2025
2025-08-26 Chinese
启迪药业集团股份公司简式权益变动报告书-启迪科服
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details a change in shareholding due to a judicial auction of shares held by the information disclosure obligor in the listed company 启迪药业集团股份公司. The document includes detailed information about the shareholders, the nature of the shareholding change, the legal basis, and the specifics of the share transfer. It is a formal report on a change in significant share ownership levels, specifically due to a judicial auction, and includes data on share quantities before and after the change. This matches the definition of a Major Shareholding Notification (Code: MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an announcement of a report publication, nor is it a financial report or management report. It is a regulatory disclosure about shareholding changes.
2025-08-12 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.